+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Mesothelioma Drug"

Mesothelioma - Pipeline Insight, 2024 - Product Thumbnail Image

Mesothelioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 210 Pages
  • Global
From
Malignant Mesothelioma - Global Strategic Business Report - Product Thumbnail Image

Malignant Mesothelioma - Global Strategic Business Report

  • Report
  • May 2024
  • 193 Pages
  • Global
From
Malignant Mesothelioma - Pipeline Insight, 2024 - Product Thumbnail Image

Malignant Mesothelioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 110 Pages
  • Global
From
Malignant Pleural Mesothelioma - Pipeline Insight, 2024 - Product Thumbnail Image

Malignant Pleural Mesothelioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
Malignant Mesothelioma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Malignant Mesothelioma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Malignant Pleural Mesothelioma - Epidemiology Forecast - 2032 - Product Thumbnail Image

Malignant Pleural Mesothelioma - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Mesothelioma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Mesothelioma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Market Spotlight: Mesothelioma - Product Thumbnail Image

Market Spotlight: Mesothelioma

  • Report
  • June 2021
  • 35 Pages
  • Global
US Mesothelioma Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Mesothelioma Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
From
From
Malignant Mesothelioma - Competitive Landscape in 2021 - Product Thumbnail Image

Malignant Mesothelioma - Competitive Landscape in 2021

  • Report
  • May 2021
  • 48 Pages
  • Global
From
Loading Indicator

Mesothelioma is a rare form of cancer that affects the lining of the lungs, abdomen, and heart. It is caused by exposure to asbestos and is difficult to treat. Oncology drugs are used to treat mesothelioma, including chemotherapy, radiation therapy, and targeted therapy. Targeted therapy is a newer form of treatment that uses drugs to target specific molecules in cancer cells, which can help slow the growth of the cancer. The mesothelioma drug market is a rapidly growing segment of the oncology drug market. It is driven by the increasing prevalence of mesothelioma, as well as the development of new treatments. Companies in the mesothelioma drug market include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. These companies are developing new drugs to treat mesothelioma, as well as providing existing treatments. Show Less Read more